Beyond the Drip: Elevating Ig Therapy Through Education and Standards
Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.
In episode 12 of Beyond the Drip, hosts Jon Love, Paula Roth, Brandon Carpenter, Pam McIntyre and Brian O’Sullivan welcome Luba Sobolevski, CEO and founder of IgNS, and Chief Clinical Officer Amy Clarke to discuss the evolving world of immunoglobulin (Ig) therapy and the 14th annual IgNS conference.
The conversation highlights why IgNS was founded: to fill critical gaps in clinician education and standardize practices for a complex, lifelong therapy. Unlike fields such as oncology, Ig therapy historically offered limited training, leaving nurses and pharmacists underprepared to manage patient care and navigate regulatory and payer requirements.
The IgNS conference, often called the “Super Bowl” of Ig therapy, brings together every sector of the industry from manufacturers and distributors to clinicians, pharmacists and infusion centers. Attendees can choose from business and clinical tracks, gaining guidance on revenue cycle management, documentation and legally defensible standards of practice.
The discussion also explores how AI and technology are transforming care, from speech-to-text documentation and data analysis to wearable monitoring, while emphasizing that clinical judgment remains irreplaceable. Patient-focused initiatives, including education and surveys, ensure standards translate into safer, more effective care.
Key Takeaways:
- Ig therapy is highly complex, with multiple indications, dosing protocols and routes of administration, creating unique challenges for clinicians and payers.
- Standardized education and competency frameworks help clinicians deliver safer, patient-centered care.
- The IgNS conference provides actionable guidance for clinical and revenue cycle professionals, including documentation, prior authorizations and payer collaboration.
- AI can streamline workflows and enhance decision-making but must be paired with expert clinical oversight.
- Patient education and feedback are essential to measure the impact of standards on care and outcomes.
This episode offers insights into how IgNS is advancing Ig therapy standards, supporting clinicians and improving patient care. Listen to the full conversation on Beyond the Drip and subscribe to stay informed on the innovations shaping infusion care.
Guest Speakers:
Luba Sobolevsky, Pharm.D., IgCP®, President | CEO at Immunoglobulin National Society Dr. Luba Sobolevsky is the President and Chief Executive Officer of the Immunoglobulin National Society (IgNS), the central, standards-setting healthcare organization in the field of Ig therapy and biologics. Dr. Sobolevsky has over 25 years of diverse leadership experience across the healthcare field, including clinical practice, education, and pharmaceutical industry. She oversees IgNS’ strategic initiatives and the development of comprehensive programs and resources that promote best clinical practices and optimal patient outcomes. She is responsible for expanding and improving interdisciplinary and industry-wide collaboration and alliances.
Dr. Sobolevsky leads IgNS’ Patient 360 division, dedicated to patient advocacy, education and outcomes research. She has been actively engaged in research and publication in areas of optimizing immunoglobulin practice, patient experience, health equity, healthcare team competencies, and the improvement of screening and diagnosis of rare diseases. Dr. Sobolevsky holds a PharmD degree from the University of Southern California and a BA from the University of California, Los Angeles.
Amy E. Clarke, DNP RN IgCN®, Chief Clinical Officer at Immunoglobulin National Society Amy Clarke brings over 30 years of nursing experience, with a strong foundation in both clinical care and operational leadership. Her work has focused extensively on advancing immunoglobulin and infusion nursing practice, and she has had the opportunity to collaborate and present alongside respected colleagues at national and international conferences, including those hosted by NHIA, INS, ACAAI, and, of course, the Immunoglobulin National Society (IgNS).
Dr. Clarke has contributed to the development of best practices in immunoglobulin therapy through co-authored publications and her involvement on several IgNS committees, including those responsible for the Ig Therapy Standards of Practice and the certification programs for nurses and pharmacists.
Beyond the Drip Co-hosts:
Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.
Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.
Pamela McIntyre, founder and owner of Expert Infusion Nurse Consulting With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing.
Brandon Carpenter, President of MedEdge Solutions Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration.
Brian O’Sullivan, President of The O’Sullivan Group Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.
